Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B‐cell lymphoma, leg type-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B‐cell lymphoma, leg type

Published:2019-04-05 Issue:5 Volume:7 Page:964-967
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Al Dhafiri Mahdi¹²^ORCID,Sicre de Fontbrune Flore³,Marinho Eduardo⁴,Deschamps Lydia⁴,Di‐Lucca Julie⁵,Crickx Beatrice¹,Descamps Vincent¹

Affiliation:

1. Department of Dermatology Bichat Hospital Paris France

2. Department of Dermatology, College of Medicine King Faisal University Al‐Ahsa Saudi Arabia

3. Department of Hematology Saint‐Louis Hospital Paris France

4. Department of Anatomopathology Bichat Hospital Paris France

5. Department of Dermatology Lausanne University Hospital Lausanne Switzerland

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2137

Reference20 articles.

1. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response

2. Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France

3. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management

4. A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type

5. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Perspectives for Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type;Chemotherapy;2023-12-08

2. Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type;Hematological Oncology;2021-08-28

3. Antineoplastics;Reactions Weekly;2019-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3